TOYAMA, JapanFrost & Sullivan awarded Fuji Chemical Industry Co. Ltd. its 2009 Asia Pacific Product Innovation Award in the category of Ingredients for Dietary Supplements for Fujis AstaREAL® astaxanthin. Fuji has developed different forms of AstaREAL, including oil and powder, and supported scientific research into its ability to positively impact eye health, muscle endurance and skin health. Fuji Health Science is the company's North American operation.
Mitsunori Nishida, president and CEO of Fuji Chemical Industry Ltd., said, It has taken us 15 years of intensive research, process development and market development to become the most vertically integrated supplier of natural astaxanthin made from the microalgae called Haematococcus pluvialis. This was possible through the collaborative efforts of Japanese, Swedish and American scientists within the Fuji group. The award certainly lifts the groups morale and highlights Fujis long term commitment for AstaREAL. Asia Pacific is an important region for us, so leveraging the industrial recognition will help us a lot in adding brand value for current and new customers.
Of particular importance to Frost & Sullivan was Fujis focus on scientific substantiation of AstaREALs efficacy and quality in production. Archana Jayarajah, industry analyst, Frost & Sullivan, said: Notably, the firms AstaREAL astaxanthin is cultivated in an ultra-clean BioDome system in Maui, Hawaii, and state-of-the-art photobioreactors in Gustavsberg, Sweden. AstaREALs safety and efficacy is supported by a set of comprehensive studies conducted on both animal models and humans to explicitly suggest the lack of any toxicological finding that renders the product safe and effective to use.